CEBPA and neoplasm: In the HL7702 hepatic cell line, transgenic β-catenin expression repressed endogenous C/EBPα expression (Wang et al, 2013), suggesting that the antagonism of C/EBPα and Wnt signaling might represent a more general mechanism in proliferation versus differentiation control and raises the possibility of an oncogene/tumor suppressor relationship.